Australia's largest stock trading and investment forum Australia's #1 stock forum

MDC medlab clinical limited

0.00%

$6.60

Ann: Shareholder Update - Restructuring Transaction, page-9

First 9 Last

Share
Profile

Follow
mikyc

191 Posts.

41

11/11/23

17:17

Post #: 70848013
Share
Originally posted by Koftan: ↑

This Looks seriously wrong. Shareholders need to vote NO, and one big invested institution should look at a class action against the Director liability insurance.

The facts as I see them are as follows;
CEO raises $$$ from shareholders and tells us the company is worth $$$$.
There is a massive conflict where a Director of Medlab appoints the company he is a partner in (Hall Chadwick) to sell Medlab.
CEO and Previous Director under Hall Chadwick drew $$ in fees and consulting over the last eight months.
CEO pays himself a redundancy and a golden handshake with shareholders' money.
CEO and Previous Director under Hall Chadwick claim after taking $$$ and bleeding the company dry over eight months. They state they can't sell it or any of the assets and then gift the entire company to the CEO for a 20% royalty payment for four years with no minimum payment and $0 upfront.

The questions the Shareholders need to ask;
How much $ did we pay the CEO Sean Hall and any related party over the last eight months? I'm talking actual money we paid, no fancy accounting principles that they don't declare as a payment as they accrued for the payment in previous years.
Who were those related parties?
How much did we pay the previous Director, Drew Townsend, over those last eight months? Same question as the CEO. I'm talking about the actual money we paid.
How much money did we pay the firm Hall Chadwick with Director Drew Townsend as a partner over the eight months?
Since Hall Chadwick could not sell, is there a refund to Shareholders from Hall Chadwick, or did the previous Director and his CEO mate write the contract to Hall Chadwick that they got paid no matter what and it wasn't performance-based?
The company has $2.7M in cash two months before halting with possible millions in R&D tax credits payable. Suppose we took that cash, those credits and the $8M in assets in the books. Given MDC has a Market cap of Approx $15M, wouldn't we get 50c in the dollar back?
How much $ per share do Medlab Shareholders get back from the sale of the assets to date, and when will we expect that payment?
How can the CEO raise money and tell us the company is worth $$$ now claim it is worth $0 and give it to him for free, and yet it's sitting on over $60M of tax losses that he can use to offset any future returns he makes? That is at least worth 10c in the dollar for the $60M of ATO reported tax losses being carried forward!
Medlab press release used words such as "no formal bids being presented." I would like to see a list of what "informal bids" we received and what Hall Chadwick classifies as not "formal bids."
Given Medlab was at $60M in tax losses in 2022. What is the final $ loss, and was any company willing to purchase the ASX listing with those tax losses to offset their earnings as an "informal bid"?
Given that Pharmacare is paying a royalty payment to Medlab for using Medlab vitamins and Nanocelle in Australia, over 100's of thousands of dollars. It isn't easy to believe that Pharmacare did not offer to purchase. Did they put in an "informal bid"?
Since the CEO is now getting the company for $0, he is technically not redundant. Will he return to shareholders his $$ golden handshake and redundancy payment?

Expand

good questions and great analysis.

unfortunately someone who uses his own family tragedies as a storyline to make up all sorts of reasons why he is genuinely vested into bringing oncology related drugs and technology to the market, yet lure funds only to bank into his and related parties, only one can wonder the ethical standards and authenticity of such individual.

this can make a great case study for students on how low personal integrity some individuals have.
MDC Price at posting: $6.60 Sentiment: None Disclosure: Not Held
6 Upvote

3 Great analysis

Reply

Top Stories

AII

A new NASDAQ listing for a key player in the global critical minerals space

BDM

Burgundy plunges -20% after turning to layoffs to navigate record-low diamond prices

SYR

Syrah jumps +19% as graphite tariff threat spurs optimism down under

PSC

Prospect's Mumbezhi Project puts it at the middle of copper's megatrend. And FQM just bought in

Listen: HotCopper Wire Podcast 018 – Potatoes, TACOs, and the $120M helicopter heist

STN

Saturn brings up seventh straight Apollo Hill upgrade on 'impressive' 300-hole drill run

SER

Strategic Energy extends its QLD copper-gold frontier with Diamantina acquisition

Week 29 Wrap: ASX hits new all time high of 8,766pts ahead of Aug 1

HotCopper Highlights: Trigg; Droneshield; Lumos & more

DRO

History repeats for DroneShield investors but carnage so far subdued

First 9 Last

Add to My Watchlist

What is My Watchlist?

A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.